Remote monitoring and digital health tools in CVD management

EN BREF ...

"The COVID-19 pandemic has accelerated the adoption and acceptance of remote monitoring and other digital approaches to cardiovascular disease management across the world. We argue that considerable additional effort is required to ensure appropriate multi-stakeholder involvement in the development, evaluation and best use of an ever-increasing number of digital technologies. The COVID-19 pandemic has led to a tech-celeration in health care, with the adoption of telemedicine tak- ing place almost overnight. A general practitioner from London was quoted in The New York Times: “We’re basi- cally witnessing 10 years of change in one week. It used to be that 95 percent of patient contact was face-to-face: you go to see your doctor, as it has been for decades, centuries. But that has changed completely”1. During this health crisis, remote consultation and monitoring, including the use of mobile-health (m-health) tools and wearables, became essential to replace (or at least to sup- port) the traditional face-to-face interaction between patients and clinicians. Reimbursement rapidly changed in many countries to support this digital transformation. It is, so far, unclear whether and to what extent health care will revert to the old ways of working once the pan- demic is subdued, or whether it will continue to embrace the challenges and opportunities that being liberated from the need for co-location of patient, data collection and decision-making bring..." En bref issu de l'étude.